![Paolo Augusto Paoletti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paolo Augusto Paoletti
Director/Board Member at
GENMAB A/S
Net worth: 666 775 $ as of 31/05/2026
Profile
Paolo Augusto Paoletti currently works at Genmab A, as Independent Director from 2015, Biomed Ltd., as Director, Akamis Bio Ltd., as Non-Executive Director, and Grid Therapeutics LLC, as Director.
Dr. Paoletti also formerly worked at Kesios Therapeutics Ltd., as Chairman & Chief Executive Officer from 2015 to 2017, Gammadelta Therapeutics Ltd., as Chief Executive Officer & Director, Forma Therapeutics, Inc., as Director, Forma Therapeutics Holdings, Inc., as Independent Non-Executive Director from 2015 to 2021, NuCana Plc, as Non-Executive Director, Eli Lilly & Co., as Vice President-Oncology Research, GSK Plc, as President-Oncology Division from 2013 to 2015, and Lilly Oncology, as Vice President-Clinical Development.
Dr. Paoletti received his doctorate degree from the University of Pisa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/02/2026 | 2,506 ( 0% ) | 666 775 $ | 31/05/2026 |
Paolo Augusto Paoletti active positions
| Companies | Position | Start |
|---|---|---|
| GENMAB A/S | Director/Board Member | 01/01/2015 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Director/Board Member | - |
Biomed Ltd.
 Biomed Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Grid Therapeutics LLC
 Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Develops and research cancer therapeutics to develop human derived antibodies | Director/Board Member | - |
Former positions of Paolo Augusto Paoletti
| Companies | Position | End |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 17/06/2021 |
Kesios Therapeutics Ltd.
 Kesios Therapeutics Ltd. BiotechnologyHealth Technology Provides biotechnology services | Chief Executive Officer | 01/01/2017 |
| GSK PLC | Corporate Officer/Principal | 01/04/2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Chief Executive Officer | - |
Training of Paolo Augusto Paoletti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Forma Therapeutics, Inc.
 Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes novel therapeutics to transform the patient living | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Biomed Ltd.
Biomed Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Pisa
 University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
NuCana Plc
 NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Kesios Therapeutics Ltd.
Kesios Therapeutics Ltd. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Health Technology |
Grid Therapeutics LLC
Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Develops and research cancer therapeutics to develop human derived antibodies | Commercial Services |
- Stock Market
- Insiders
- Paolo Augusto Paoletti
